Passage Bio Appoints Richard Morris as Chief Financial Officer
PHILADELPHIA, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV-delivered gene therapies for the treatment of rare monogenic central nervous system diseases, today announced the appointment of Richard Morris as chief …